Latest Headlines
U.S. drug maker Eli Lilly and Co. said it stopped its Phase II study of a promising drug to slow Alzheimer's disease over concerns about potential liver damage.
The U.S. Food and Drug Administration has ended its hold on PharmAthene's proposed Phase II study of SparVax, a next-generation recombinant anthrax vaccine.
Patients with a type of lymphoma who received chemotherapy but not radiation therapy to the thorax had excellent outcomes, U.S. researchers say.
Canadian modeling and simulation company CAE has received $128 million in contracts for on U.S. and Australian military projects.
The U.S. Food and Drug Administration approved Quartette -- levonorgestrel/ethinyl estradiol and ethinyl estradiol -- tablets to prevent pregnancy.
An anti-copper drug compound that disables bone marrow cells from receiving migrating cancer tumor cells may curb the spread of cancer, U.S researchers say.
Many women with low-grade carcinoma of the ovary have seen their tumors stabilize or shrink after using the drug selumetinib, U.S. researchers said.
The U.S. Army has given BAE Systems a $55 million, Phase II contract for engineering changes to Bradley Fighting Vehicles.
Boeing reports it has received a U.S. Army contract for continued development of technology to improve helicopter maneuverability and performance.
Northrop Grumman's offering for a U.S. Department of Homeland Security sensor acquisition program has completed a rigorous field test.
First  Prev |
Page 1 of 14
|
|
